1396 related articles for article (PubMed ID: 16610494)
21. KSHV/HHV8-associated intestinal Kaposi's sarcoma in patient with ulcerative colitis receiving immunosuppressive drugs: report of a case.
Svrcek M; Tiret E; Bennis M; Guyot P; Fléjou JF
Dis Colon Rectum; 2009 Jan; 52(1):154-8. PubMed ID: 19273971
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
Chan DJ
Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
[No Abstract] [Full Text] [Related]
23. [Mastitis-like changes as debut symptom of Kaposi's sarcoma and AIDS].
Kjaer C; Helleberg M
Ugeskr Laeger; 2009 Oct; 171(41):3008-9. PubMed ID: 19814931
[TBL] [Abstract][Full Text] [Related]
24. Regression of Kaposi's sarcoma lesions following highly active antiretroviral therapy in an HIV-infected patient.
Kumarasamy N; Venkatesh KK; Devaleenol B; Poongulali S; Ahilasamy N
Int J STD AIDS; 2008 Nov; 19(11):786-8. PubMed ID: 18931277
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma.
Bihl F; Berger C; Chisholm JV; Henry LM; Bertisch B; Trojan A; Nadal D; Speck RF; Flepp M; Brander C; Mueller NJ;
AIDS; 2009 Sep; 23(14):1918-22. PubMed ID: 19609199
[TBL] [Abstract][Full Text] [Related]
26. [Diagnostic image (335). A man with tumours in the oral cavity].
Hartgerink-Lutgens I; Kremer B
Ned Tijdschr Geneeskd; 2007 Aug; 151(31):1729. PubMed ID: 17784695
[TBL] [Abstract][Full Text] [Related]
27. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
[TBL] [Abstract][Full Text] [Related]
28. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
29. Parotid mass as an early sign of Kaposi's sarcoma associated with human herpesvirus 8 infection.
Puxeddu R; Parodo G; Locci F; Puxeddu I; Manconi PE; Ferreli C
J Laryngol Otol; 2002 Jun; 116(6):470-3. PubMed ID: 12385365
[TBL] [Abstract][Full Text] [Related]
30. AIDS associated Kaposi's sarcoma.
Thomas S; Sindhu CB; Sreekumar S; Sasidharan PK
J Assoc Physicians India; 2011 Jun; 59():387-9. PubMed ID: 21751599
[TBL] [Abstract][Full Text] [Related]
31. Kaposi's sarcoma of an intraparotid lymph node leading to a diagnosis of HIV.
Steele NP; Sampogna D; Sessions RB
Laryngoscope; 2005 May; 115(5):861-3. PubMed ID: 15867654
[TBL] [Abstract][Full Text] [Related]
32. Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L; Zolfo M; Huyst V; Louis F; Barnardt P; Van de Velde A; De Schacht C; Colebunders R
AIDS Rev; 2005; 7(1):13-21. PubMed ID: 15875657
[TBL] [Abstract][Full Text] [Related]
33. [Knotty skin tumors of an 80-year-old patient presenting with estimated diagnosis of chronic venous insufficiency].
Koch S; Göbels K; Oette M; Feldt T; Leidel R; Häussinger D
Med Klin (Munich); 2005 Nov; 100(11):744-6. PubMed ID: 16328183
[TBL] [Abstract][Full Text] [Related]
34. HIV-associated Kaposi's sarcoma.
Seybold U; Mayr D; Degenhart C; Bogner JR
Infection; 2008 Feb; 36(1):96-7. PubMed ID: 18231715
[No Abstract] [Full Text] [Related]
35. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
[TBL] [Abstract][Full Text] [Related]
36. Highly active antiretroviral therapy for the treatment of Kaposi's sarcoma associated with primary human immunodeficiency virus type-1 infection.
Genka I; Yasuoka A; Saitoh K; Oka S
Jpn J Infect Dis; 2000 Aug; 53(4):166-7. PubMed ID: 11056560
[No Abstract] [Full Text] [Related]
37. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
38. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
39. Trends in Kaposi's sarcoma survival disparities in the United States: 1980 through 2004.
Datta GD; Kawachi I; Delpierre C; Lang T; Grosclaude P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2718-26. PubMed ID: 20861396
[TBL] [Abstract][Full Text] [Related]
40. Aetiology of Kaposi's sarcoma: current understanding and implications for therapy.
Boshoff C; Weiss RA
Mol Med Today; 1997 Nov; 3(11):488-94. PubMed ID: 9430784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
